These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16396645

  • 1. Screening compliance and visual outcome in diabetes.
    Zoega GM, Gunnarsdóttir T, Björnsdóttir S, Hreietharsson AB, Viggósson G, Stefánsson E.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):687-90. PubMed ID: 16396645
    [Abstract] [Full Text] [Related]

  • 2. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK.
    Acta Ophthalmol Scand Suppl; 1997 Dec; (223):1-76. PubMed ID: 9559048
    [Abstract] [Full Text] [Related]

  • 3. Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease.
    Olafsdottir E, Andersson DK, Stefánsson E.
    Acta Ophthalmol Scand; 2007 Feb; 85(1):40-5. PubMed ID: 17244208
    [Abstract] [Full Text] [Related]

  • 4. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M, Nilsson A, Janzon L, Groop L.
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [Abstract] [Full Text] [Related]

  • 5. [Diabetic retinopathy and associated risk factors in type-1 and type-2 diabetics in the Upper Palatinate].
    Zietz B, Kasparbauer A, Ottmann S, Spiegel D, Palitzsch KD.
    Dtsch Med Wochenschr; 2000 Jun 23; 125(25-26):783-8. PubMed ID: 10916493
    [Abstract] [Full Text] [Related]

  • 6. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
    Scanlon PH, Foy C, Chen FK.
    Br J Ophthalmol; 2008 Jun 23; 92(6):775-8. PubMed ID: 18356262
    [Abstract] [Full Text] [Related]

  • 7. Does functional vision behave differently in low-vision patients with diabetic retinopathy?--A case-matched study.
    Ahmadian L, Massof R.
    Invest Ophthalmol Vis Sci; 2008 Sep 23; 49(9):4051-7. PubMed ID: 18552389
    [Abstract] [Full Text] [Related]

  • 8. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P, Baget M, Mendez I, Fernández J, Salvat M, Martinez I.
    J Diabetes Complications; 2007 Sep 23; 21(3):172-80. PubMed ID: 17493551
    [Abstract] [Full Text] [Related]

  • 9. The effect of low vision rehabilitation in diabetic eye disease: a randomised controlled trial protocol.
    Dunbar HM, Crossland MD, Bunce C, Egan C, Rubin GS.
    Ophthalmic Physiol Opt; 2012 Jul 23; 32(4):282-93. PubMed ID: 22620493
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study.
    Broadbent DM, Scott JA, Vora JP, Harding SP.
    Eye (Lond); 1999 Apr 23; 13 ( Pt 2)():160-5. PubMed ID: 10450374
    [Abstract] [Full Text] [Related]

  • 11. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M, Dzivgielewski K.
    Klin Oczna; 2006 Apr 23; 108(1-3):66-9. PubMed ID: 16883944
    [Abstract] [Full Text] [Related]

  • 12. A portable visual acuity device used in diabetic retinal screening.
    Kehler LF, Kehler KB, Merin LM, Tsai JC.
    Am J Ophthalmol; 2007 Mar 23; 143(3):514-5. PubMed ID: 17317400
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diabetes eye screening in the Wellington region of New Zealand: characteristics of the enrolled population (2002-2005).
    Frederikson LG, Jacobs RJ.
    N Z Med J; 2008 Mar 14; 121(1270):21-34. PubMed ID: 18364752
    [Abstract] [Full Text] [Related]

  • 15. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L.
    Br J Ophthalmol; 2008 Jan 14; 92(1):89-92. PubMed ID: 17584999
    [Abstract] [Full Text] [Related]

  • 16. [Macular oedema and intravitreal triamcinolone injections].
    Gunnlaugsdóttir E, Oehman DO, Gunnarsdóttir SG, Stefánsson E.
    Laeknabladid; 2006 Dec 14; 92(12):847-57. PubMed ID: 17206015
    [Abstract] [Full Text] [Related]

  • 17. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    PKC-DRS2 GroupBeetham Eye Institute, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. LPAiello@Joslin.Harvard.edu, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.
    Ophthalmology; 2006 Dec 14; 113(12):2221-30. PubMed ID: 16989901
    [Abstract] [Full Text] [Related]

  • 18. [Programme preventing vision loss due to diabetes].
    Bandurska-Stankiewicz E, Wiatr D.
    Klin Oczna; 2007 Dec 14; 109(7-9):359-62. PubMed ID: 18260299
    [Abstract] [Full Text] [Related]

  • 19. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes.
    Soto-Pedre E, Hernaez-Ortega MC, Piniés JA.
    Ophthalmic Epidemiol; 2007 Dec 14; 14(2):76-9. PubMed ID: 17464854
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of state of the organ of sight in patients with diabetes type II].
    Wilczyński M, Dziegielewski K.
    Klin Oczna; 2005 Dec 14; 107(10-12):672-4. PubMed ID: 16619817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.